Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Abstract In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, n = 48), polycythemia vera (PV, n = 42), myelofibrosis (MF, n = 56), and prefibrotic myelofibrosis (pre-PMF, n = 16), 15 major thromboses (3 arterial and 12 venous)...
Full description
Bibliographic Details
Main Authors: |
Tiziano Barbui,
Valerio De Stefano,
Alberto Alvarez-Larran,
Alessandra Iurlo,
Arianna Masciulli,
Alessandra Carobbio,
Arianna Ghirardi,
Alberto Ferrari,
Valeria Cancelli,
Elena Maria Elli,
Marcio Miguel Andrade-Campos,
Mercedes Gasior Kabat,
Jean-Jaques Kiladjian,
Francesca Palandri,
Giulia Benevolo,
Valentin Garcia-Gutierrez,
Maria Laura Fox,
Maria Angeles Foncillas,
Carmen Montoya Morcillo,
Elisa Rumi,
Santiago Osorio,
Petros Papadopoulos,
Massimiliano Bonifacio,
Keina Susana Quiroz Cervantes,
Miguel Sagues Serrano,
Gonzalo Carreno-Tarragona,
Marta Anna Sobas,
Francesca Lunghi,
Andrea Patriarca,
Begoña Navas Elorza,
Anna Angona,
Elena Magro Mazo,
Steffen Koschmieder,
Giuseppe Carli,
Beatriz Cuevas,
Juan Carlos Hernandez-Boluda,
Emma Lopez Abadia,
Blanca Xicoy Cirici,
Paola Guglielmelli,
Marta Garrote,
Daniele Cattaneo,
Rosa Daffini,
Fabrizio Cavalca,
Beatriz Bellosillo,
Lina Benajiba,
Natalia Curto-Garcia,
Marta Bellini,
Silvia Betti,
Claire Harrison,
Alessandro Rambaldi,
Alessandro Maria Vannucchi |
Format: | Article
|
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Blood Cancer Journal
|
Online Access: | https://doi.org/10.1038/s41408-021-00417-3
|